Laurie A. Burlingame has a diverse practice representing clients on a broad spectrum of transactions in the life sciences and technology industries, including initial and follow-on public offerings, venture capital financings, de-SPAC transactions, and mergers and acquisitions (M&A). She regularly serves as outside general counsel to clients, advising management teams and boards of directors on a variety of matters throughout the lifecycles of various companies, including formation and founder issues, licensing transactions, strategic collaborations, commercial transactions, corporate governance, disclosure requirements, and other general corporate matters.